IP Library Granted Patent US 6,905,837
Granted Patent B2
US 6,905,837 · App. 10/208,557 · Granted Jun 14, 2005

Method for screening restriction endonucleases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,905,837
App. No.
10/208,557
Granted
Jun 14, 2005
Kind
B2
Abstract

A method is provided for identifying a restriction endonuclease, which includes the steps of (a) screening a target DNA sequence for the presence of known methylase sequence motifs, (b) identifying any open reading frames which lie close to the methylase sequence motifs screened in step (a), and (c) assaying the protein products of these open reading frames for restriction endonuclease activity. Methods for identifying isoschizomers of known restriction endonucleases, which isoschizomers possess a desired physical property, such as thermostability, are also provided by the present invention, as are several novel restriction endonucleases isolated from M. jannaschii , MjaIII and MjaIV. Additionally, a gene was identified that encoded a previously observed endonuclease activity, designated MjaII. Also provided by the present invention are vectors suitable for cloning a DNA sequence encoding a cytotoxic protein, via independent transcription promotors which may be selectively controlled by several conditions. A method for producing these cytotoxic proteins using such vectors is also provided, as are stable clones of PacI and NlaIII.

Claims (8)

1. A method of identifying an isoschizomer of a known restriction endonuclease, said method comprising the steps of:

(a) identifying the open reading frame in genomic DNA encoding said known restriction endonuclease;

(b) comparing said open reading frame of step (a) against known open reading frames in at least one organism to identify potential sequence matches; and

(c) assaying the protein products of the open reading frames of step (b) for restriction endonuclease activity.

2. The method of claim 1 , wherein said organism is selected from the group consisting of thermostable, halostable, acidostable, and cryostable organisms.

3. The method of claim 1 , wherein said comparison of step (b) comprises searching DNA sequence databases.

4. The method of claim 1 , wherein said protein products of step (c) are produced by in vitro transcription and translation.

5. The method of claim 1 , wherein said protein products of step (c) are produced by recombinant DNA techniques.

Assignments (4)
CONFIRMATORY LICENSE Recorded Feb 7, 2011
From: NEW ENGLAND BIOLABS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025750/0048 →
CHANGE OF NAME Recorded Oct 20, 2004
From: HEIDELBERG WEB SYSTEMS, INC.
To: GOSS INTERNATIONAL AMERICAS, INC.
Reel/Frame 015886/0713 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2004
From: HEIDELBERGER DRUCKMASCHINEN AG
To: HEIDELBERG WEB SYSTEMS, INC.
Reel/Frame 015886/0211 →
SECURITY AGREEMENT Recorded Sep 2, 2004
From: HEIDELBERG WEB SYSTEMS, INC., A DELAWARE CORPORATION
To: U.S. BANK, N.A.
Reel/Frame 015722/0435 →